Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12187 | 926 | 33.7 | 50% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
2447 | 2 | DYSFIBRINOGENEMIA//AFIBRINOGENEMIA//FIBRINOGEN | 4049 |
12187 | 1 | CANCER PROCOAGULANT//TUMOR PROCOAGULANT//CANCER CELL DERIVED BLOOD COAGULATING ACTIVITY 1 | 926 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CANCER PROCOAGULANT | authKW | 454802 | 2% | 69% | 20 |
2 | TUMOR PROCOAGULANT | authKW | 98922 | 0% | 100% | 3 |
3 | CANCER CELL DERIVED BLOOD COAGULATING ACTIVITY 1 | authKW | 65948 | 0% | 100% | 2 |
4 | CANCER PROCOAGULANT CP | authKW | 65948 | 0% | 100% | 2 |
5 | IBSIB | address | 65948 | 0% | 100% | 2 |
6 | INVASION & METASTASIS | journal | 50843 | 3% | 6% | 26 |
7 | BIOCHEM IBSIB | address | 43964 | 0% | 67% | 2 |
8 | HISTOL EMBRIOL GENET | address | 43964 | 0% | 67% | 2 |
9 | LODGEMENT | authKW | 43964 | 0% | 67% | 2 |
10 | PL SHUPIK KYIV MED POST EDUC | address | 43964 | 0% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 8209 | 49% | 0% | 451 |
2 | Hematology | 2078 | 15% | 0% | 139 |
3 | Peripheral Vascular Diseases | 595 | 8% | 0% | 75 |
4 | Medicine, Research & Experimental | 198 | 7% | 0% | 61 |
5 | Pharmacology & Pharmacy | 106 | 9% | 0% | 82 |
6 | Endocrinology & Metabolism | 80 | 5% | 0% | 45 |
7 | CYTOLOGY & HISTOLOGY | 62 | 0% | 0% | 4 |
8 | Pathology | 56 | 3% | 0% | 27 |
9 | Cell Biology | 39 | 6% | 0% | 51 |
10 | Medicine, General & Internal | 23 | 4% | 0% | 38 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IBSIB | 65948 | 0% | 100% | 2 |
2 | BIOCHEM IBSIB | 43964 | 0% | 67% | 2 |
3 | HISTOL EMBRIOL GENET | 43964 | 0% | 67% | 2 |
4 | PL SHUPIK KYIV MED POST EDUC | 43964 | 0% | 67% | 2 |
5 | BIOCHEM ENVIRONM BIOANAL | 32974 | 0% | 100% | 1 |
6 | CONSORZIO MARIO NEGRI SUD S MARIA IMBARO | 32974 | 0% | 100% | 1 |
7 | GYNECOL VIA OSPED 46 | 32974 | 0% | 100% | 1 |
8 | IFR ST LOUIS HEMATOL | 32974 | 0% | 100% | 1 |
9 | INDEPENDENT BIOPHARM | 32974 | 0% | 100% | 1 |
10 | INT PHARM HLTH SCI | 32974 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INVASION & METASTASIS | 50843 | 3% | 6% | 26 |
2 | CLINICAL & EXPERIMENTAL METASTASIS | 12923 | 3% | 1% | 28 |
3 | PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | 5403 | 1% | 1% | 12 |
4 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 5035 | 2% | 1% | 17 |
5 | THROMBOSIS RESEARCH | 4365 | 4% | 0% | 37 |
6 | CANCER RESEARCH | 4313 | 8% | 0% | 72 |
7 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 4144 | 1% | 1% | 10 |
8 | HAEMOSTASIS | 3821 | 1% | 1% | 12 |
9 | CANCER AND METASTASIS REVIEWS | 3259 | 1% | 1% | 11 |
10 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 2196 | 2% | 0% | 18 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GORDON, SG , MIELICKI, WP , (1997) CANCER PROCOAGULANT: A FACTOR X ACTIVATOR, TUMOR MARKER AND GROWTH FACTOR FROM MALIGNANT TISSUE.BLOOD COAGULATION & FIBRINOLYSIS. VOL. 8. ISSUE 2. P. 73 -86 | 58 | 60% | 43 |
2 | HONN, KV , TANG, DG , CHEN, YQ , (1992) PLATELETS AND CANCER METASTASIS - MORE THAN AN EPIPHENOMENON.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 18. ISSUE 4. P. 392 -415 | 72 | 38% | 114 |
3 | HONN, KV , TANG, DG , CRISSMAN, JD , (1992) PLATELETS AND CANCER METASTASIS - A CAUSAL RELATIONSHIP.CANCER AND METASTASIS REVIEWS. VOL. 11. ISSUE 3-4. P. 325 -351 | 57 | 38% | 205 |
4 | NIGAM, S , ZAKRZEWICZ, A , ESKAFI, S , ROSCHER, A , (1992) CLINICAL-SIGNIFICANCE OF PROSTACYCLIN AND THROMBOXANE IN CANCER OF THE FEMALE BREAST AND GENITAL-TRACT.CANCER AND METASTASIS REVIEWS. VOL. 11. ISSUE 3-4. P. 411 -420 | 36 | 68% | 10 |
5 | GORDON, SG , (1992) CANCER CELL PROCOAGULANTS AND THEIR ROLE IN MALIGNANT DISEASE.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 18. ISSUE 4. P. 424-433 | 49 | 43% | 50 |
6 | GORDON, SG , (1992) CANCER CELL PROCOAGULANTS AND THEIR IMPLICATIONS.HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. VOL. 6. ISSUE 6. P. 1359-1374 | 51 | 42% | 24 |
7 | HEINMOLLER, E , WEINEL, RJ , HEIDTMANN, HH , SALGE, U , SEITZ, R , SCHMITZ, I , MULLER, KM , ZIRNGIBL, H , (1996) STUDIES ON TUMOR-CELL INDUCED PLATELET AGGREGATION IN HUMAN LUNG CANCER CELL LINES.JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. VOL. 122. ISSUE 12. P. 735-744 | 29 | 60% | 30 |
8 | CHIANG, HS , SWAIM, MW , HUANG, TF , (1995) CHARACTERIZATION OF PLATELET-AGGREGATION INDUCED BY HUMAN BREAST-CARCINOMA AND ITS INHIBITION BY SNAKE-VENOM PEPTIDES, TRIGRAMIN AND RHODOSTOMIN.BREAST CANCER RESEARCH AND TREATMENT. VOL. 33. ISSUE 3. P. 225-235 | 28 | 67% | 16 |
9 | COSTANTINI, V , ZACHARSKI, LR , (1993) FIBRIN AND CANCER.THROMBOSIS AND HAEMOSTASIS. VOL. 69. ISSUE 5. P. 406-414 | 37 | 47% | 67 |
10 | KATO, Y , FUJITA, N , YANO, H , TSURUO, T , (1997) SUPPRESSION OF EXPERIMENTAL LUNG COLONIZATION OF MOUSE COLON ADENOCARCINOMA 26 IN VIVO BY AN ANTI-IDIOTYPE MONOCLONAL ANTIBODY RECOGNIZING A PLATELET SURFACE MOLECULE.CANCER RESEARCH. VOL. 57. ISSUE 14. P. 3040-3045 | 24 | 67% | 13 |
Classes with closest relation at Level 1 |